Agree on VVUS...but not on selling CBST.

VVUS held up well today considering the market sell-off...shorts tried to smash it down again, like ARNA was hit, but some entity was stepping in and buying up everything they threw at it; 2 times volume and VVUS still finished in the green. The VVUS risk/reward is about as favorable as you will find in dev. biotech...

Bodes well for the future for VVUS. VVUS conference call coming next week and I keep thinking maybe ROW partner announcement, or JPM will finally initiate coverage soon in exchange for the recent $10.50 offering they ran for VVUS.

Qnexa is going to be a multi-billion dollar blockbuster...addressing a 90 million person market in the U.S. alone.